store at low temperature,keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ryuvidine is a dual inhibitor of KDM5A and SETD8, an inducer of the DNA damage response with potential anticancer activity, inhibition of H4K20 methylation, and inhibition of CDK4, and can be used to study breast cancer and erythroplasia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 61.00 | |
5 mg | In stock | $ 148.00 | |
10 mg | In stock | $ 218.00 | |
25 mg | In stock | $ 372.00 | |
50 mg | In stock | $ 549.00 | |
100 mg | In stock | $ 783.00 |
Description | Ryuvidine is a dual inhibitor of KDM5A and SETD8, an inducer of the DNA damage response with potential anticancer activity, inhibition of H4K20 methylation, and inhibition of CDK4, and can be used to study breast cancer and erythroplasia. |
Targets&IC50 | CDK4:6.0 μM |
Molecular Weight | 284.33 |
Formula | C15H12N2O2S |
CAS No. | 265312-55-8 |
store at low temperature,keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: 2 mg/mL (2.65 mM), Sonication is recommended.
DMSO: 1 mg/mL (3.52 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ryuvidine 265312-55-8 Cell Cycle/Checkpoint Chromatin/Epigenetic Histone Demethylase Histone Methyltransferase CDK inhibitor inhibit